We demonstrate a general approach for metabolic engineering of biocatalytic systems comprising the uses of a chemostat for strain improvement and radioisotopic tracers for the quantification of pathway fluxes. Flux determination allows the identification of target pathways for modification as validated by subsequent overexpression of the corresponding gene. We demonstrate this method in the indene bioconversion network of Rhodococcus modified for the overproduction of 1,2-indandiol, a key precursor for the AIDS drug Crixivan. C omplex metabolic and bioconversion pathways containing parallel, branching, and͞or reversible reactions can be studied quantitatively under the framework of metabolic engineering, which uses steady-state fluxes as fundamental determinants of cell physiology (1, 2). It is necessary to use these methods to distinguish the relative importance of competing metabolic reactions to guide target selection for the improvement of biological production of secondary metabolites or small molecules important for pharmaceutical and materials applications (3). To date, applications of metabolic engineering have been limited to primarily linear pathways and cases in which the relevant biochemistry and associated genetics are well established. In many cases, efforts focusing on transformation of cells by ad hoc methods have failed where genes are introduced based on conclusions derived in the absence of quantitative analysis of pathways. Consequently, an approach that considers the systemic properties of a bioconversion to identify rational targets is valuable. Such an approach can be based on determination of fluxes in bioconversion networks, which has been a focus of metabolic engineering for the past 10 years.
We demonstrate a general approach for metabolic engineering of biocatalytic systems comprising the uses of a chemostat for strain improvement and radioisotopic tracers for the quantification of pathway fluxes. Flux determination allows the identification of target pathways for modification as validated by subsequent overexpression of the corresponding gene. We demonstrate this method in the indene bioconversion network of Rhodococcus modified for the overproduction of 1,2-indandiol, a key precursor for the AIDS drug Crixivan. C omplex metabolic and bioconversion pathways containing parallel, branching, and͞or reversible reactions can be studied quantitatively under the framework of metabolic engineering, which uses steady-state fluxes as fundamental determinants of cell physiology (1, 2) . It is necessary to use these methods to distinguish the relative importance of competing metabolic reactions to guide target selection for the improvement of biological production of secondary metabolites or small molecules important for pharmaceutical and materials applications (3) . To date, applications of metabolic engineering have been limited to primarily linear pathways and cases in which the relevant biochemistry and associated genetics are well established. In many cases, efforts focusing on transformation of cells by ad hoc methods have failed where genes are introduced based on conclusions derived in the absence of quantitative analysis of pathways. Consequently, an approach that considers the systemic properties of a bioconversion to identify rational targets is valuable. Such an approach can be based on determination of fluxes in bioconversion networks, which has been a focus of metabolic engineering for the past 10 years.
We have developed and applied a general framework for the optimization of bioconversion systems in the context of the directed biocatalytic production of trans-(1R,2R)-indandiol suitable for the synthesis of the HIV protease inhibitor Crixivan (Merck). Chartrain et al. (4) isolated Rhodococcus sp. I24, which possesses the required oxygenase enzyme activities for converting indene to (2R)-indandiol (Fig. 1) . The Crixivan chiral precursor (Ϫ),-cis-(1S,2R)-1-aminoindan-2-ol [(Ϫ)-CAI] can then be synthesized from (2R)-indandiol through a Ritter reaction (5, 6) . However, besides the desired (2R)-indandiol product, several other side-products are secreted also in a Rhodococcus sp. I24 fermentation that reduce the desired product yield and selectivity. Therefore, it is of interest to modify I24 genetically to eliminate undesirable reactions and enhance the productforming pathway. Because of the poorly characterized nature of I24 genetics a priori, it is imperative that an approach be developed to prioritize network targets for modification in light of the current state of knowledge of the given biological system.
The general framework described here is comprised of five essential steps: (i) establishment of an experimental system for strain selection and metabolic network analysis, (ii) definition of the bioconversion network, (iii) quantification of network fluxes, (iv) target identification, and (v) flux redistribution. In this study, a systematic evaluation of the physiology of Rhodococcus strains and determination of the relative fluxes of the indene bioconversion network facilitated the improvement of (2R)-indandiol production suitable for Crixivan manufacturing.
Materials and Methods
Bacterial Growth and Preparation of Cell Lysates. Rhodococcus sp. I24 was isolated by Merck scientists from soil contaminated with toluene (7). Strain KY1 was isolated during a continuous fermentation of I24. Stock culture vials of I24 and KY1 were stored at Ϫ80°C in LB medium supplemented with 25% glycerol. Working cultures of all strains were grown and maintained on LB plates streaked from frozen stocks. KY1 cultures were cultivated at 30°C in LB medium, whereas KY1(pDS3) and KY1(pAL282) cultures required 10 g͞ml gentimicin sulfate for selection.
Cell lysates were prepared by centrifuging the cells at 14,000 ϫ g. The supernatant was removed, and the cells were washed in lysis buffer containing 100 mM Hepes, 10% glycerol, 0.2 mM ␤-mercaptoethanol, and 2 tablets per 50 ml of protease inhibitor mixture (Complete, EDTA-free, Roche Molecular Biochemicals) at pH 7.0 and 4°C. The cells were centrifuged and resuspended in lysis buffer at 4°C. The cells were passed through a prechilled French press at 16,000 psi three times. The crude lysate was cleared by centrifugation, and the top fraction was collected and stored at Ϫ20°C until use. Bioconversions. The fermentor was inoculated with 25 ml of preculture grown in a shake flask. Both the medium and indene feeds were initiated when the fermentor culture reached an OD 600 of Ϸ15, corresponding to midexponential growth of the culture. The feed medium was the same as the respective fermentor medium except 25 ml͞liter 1 M phosphate buffer was used instead of 35.2 ml͞liter in the KY1 chemostat. For continuous cultures, a constant volume of 1 liter was maintained in the fermentor. Indene bioconversions performed in batch mode used the same fermentation system and defined medium except for the addition of 10 mg͞liter gentimicin for selection where appropriate. The defined medium described above was used for cell growth, because indene is not used as a carbon source by the strains described here. The indene feed was initiated when the fermentor culture reached an OD 600 of Ϸ5 (early exponential growth).
The indene and other inducers (naphthalene and toluene) were fed separately to the fermentor by using an air-delivery system consisting of two air streams: one air stream was passed through the appropriate inducer contained in a flask and then combined with another air stream to dilute the inducer air concentration. The flow rates of each air stream were adjusted for a total flow rate of 1.0 liter͞min with the desired inducer concentration. The inducer concentration was measured by using a Pine Environmental Services Photovac 2020 photoionization detector set with a response factor of 0.3 for both indene and naphthalene and 0.5 for toluene.
14 C-Tracer Experiments. A 15-ml culture sample was removed from the chemostat under steady-state conditions (constant biomass concentration after at least four residence times) during induction. The sample was placed in a 125-ml screw-cap shake flask. HPLC Assays. Indene metabolite concentrations were measured by using a reverse-phase HPLC assay with a Zorbax RX-C8 column (4.6 mm ϫ 25 cm, Hewlett-Packard) and a separate chiral assay using a normal phase HPLC Chiralpak AD column (Chiral Technologies, Exton, PA) as described by Chartrain et al. (4). 14 C radioactive counts were measured as described elsewhere (8) . The ee of the cis-[ C-tracer studies was calculated by using the total counts of each enantiomer separated by using an HPLC assay with a Chiralpak OJ column running an isocratic elution of 90% hexane and 10% isopropyl alcohol as described elsewhere (9) .
Plasmid Construction. The limA gene (GenBank accession no. Y18005) was synthesized artificially based on the published sequence and then inserted downstream of a truncated P L promoter in a Gent R plasmid, pDS3, capable of replication in both Escherichia coli and Rhodococcus sp. KY1 ( Fig. 2; ref. 10 ). The blank control plasmid pAL282 was prepared by deleting the EcoRI restriction fragment that contained the limA ORF from pDS3. Epoxide Hydrolase Activity Assay. Cell lysate (1-5 ml) was placed in a 125-ml screw-cap shake flask, and (1S,2R)-indan oxide (83% ee) was added to a final concentration of 8 mM. The lysate was incubated at 30°C and agitated at 300 rpm. HPLC analysis was performed as described above.
Indan Oxide Hydrolysis Assay. Culture medium (10 ml), adjusted from pH 5.0-10.0, was placed in a 125-ml screw-cap shake flask, and (1S,2R)-indan oxide (83% ee) was added to a final concentration of 1.0 mM. The flasks were incubated at 30°C and agitated at 300 rpm. Samples were taken for HPLC analysis for 12 h after indan oxide addition.
Results

Experimental System for Strain Improvement and Network Analysis.
A gas-phase indene-delivery system was developed and implemented in chemostat operation for indene bioconversion. Physiological studies using metabolic flux analysis are carried out preferably in continuous flow systems that can attain a metabolic steady state. Steady states were obtained at different indene air-feed concentrations below 200 ppm and dilution rates below 0.10 h
Ϫ1
. Indene-feed concentrations above 200 ppm were toxic to the cells in the chemostat, resulting in cell washout. I24 was grown in the chemostat at a dilution rate of 0.10 h Ϫ1 under indene air-feed concentrations of 85 and 120 ppm.
At the initial steady state of 85 ppm indene air feed concentration, cis-indandiol, 1-indenol, 1-indanone, and 1-keto-2-hydroxy-indan were observed (Fig. 3) . The first three products are hypothesized to be caused by a toluene-inducible dioxygenase activity in I24 similar to that observed in Pseudomonas (11) . A new steady state was sought by increasing the indene-feed concentration to 120 ppm. After Ϸ200 h of continuous operation, distinct changes in the indene metabolite concentration profiles were evident. 1-indenol and 1-indanone were no longer produced by the cells and were washed out of the chemostat. Concurrent with this change, indan oxide and trans-indandiol production was detected, whereas the cis-indandiol concentration decreased and the 1-keto-2-hydroxy-indan concentration increased from their previous steady-state levels. These changes suggest that a mutant strain deficient in the oxygenase activity producing 1-indenol and 1-indanone was selected in the chemostat. A second chemostat running in parallel under similar conditions exhibited very similar behavior. Furthermore, cells obtained at the end of these runs were isolated and found to be stable in terms of the excreted array of metabolites for over 900 h in subsequent chemostat runs. The (2R)-indandiol yield and selectivity for KY1 increased up to 2-fold relative to I24 ( Table   1 ). The appearance of KY1 suggests that the genes encoding the oxygenase enzyme(s) responsible for 1-indenol and 1-indanone biosynthesis were mutated. A Southern hybridization analysis of I24 and KY1 genomic DNA revealed that there were significant deletions in the KY1 genome, mostly in a 340-kb megaplasmid that resides in I24 but was not detected in KY1 (unpublished data).
The emergence of the KY1 strain validates the role of a chemostat in metabolic engineering as a selective tool for strain improvement, particularly for cases in which elimination of reactions giving toxic side-products is desired. The isolation of KY1 highlights the rather unconventional use of the chemostat for the evolution of strains with improved bioconversion properties, which contrasts with its traditional application to cellphysiology studies. In this unique case, the bioconversion substrate (indene) is decoupled from the growth substrate (glucose), and cell growth presumably is limited by the toxic nature of indene and not the absence of a critical substrate. This unusual feature of indene bioconversion allowed us to maintain the biocatalyst under well defined environmental conditions with respect to both substrates for the purpose of strain selection and to simultaneously study the effect of the bioconversion substrate on cell physiology through the quantification of network fluxes. In this sense, the chemostat allowed us to (i) define a steady environment and apply selective pressure to I24, which resulted in the isolation of KY1, and (ii) systematically study the different steps of the bioconversion process. The details of this second application of the chemostat to indene bioconversion are provided below.
Definition of the Indene Bioconversion Network. To characterize the physiological differences between strains I24 and KY1, the strains were cultivated in separate chemostats and, after steady states were attained, were induced by toluene, naphthalene, or indene. The physiological state of the culture was evaluated by probing the corresponding monooxygenase and dioxygenase activities with the introduction of ]indan oxide were detected after 2 h, similar to the uninduced profiles of both strains I24 and KY1, attributable to the enzyme induction caused by the tracer itself. Therefore, KY1 seems to either be defective in the mechanism of toluene induction, contain a mutated gene encoding an inactive toluene-inducible dioxygenase, or lack some portion of this dioxygenase gene altogether.
Under naphthalene induction, the 14 C product profiles for I24 and KY1 were virtually identical. The [ 14 C]indene was converted completely to cis-indandiol and 1-indenol within 5 min. The only subtle difference between the two strains was that I24 produces cis-(1R,2S)-indandiol of 77% ee, whereas KY1 produces cis-(1R,2S)-indandiol of Ͼ99% ee. The cis-(1R,2S)-indandiol and 1-indenol are believed to be products of a naphthalene-inducible dioxygenase (NidAB) characterized previously (12) . The enantiomeric mixture of cis-indandiol produced by I24 (also observed by Chartrain, et al in ref. 4) indicates that cross-induction is occurring between at least two dioxygenases in I24. This crossinduction does not occur in KY1 because of its altered or deleted toluene-inducible dioxygenase gene.
As expected, strains I24 and KY1 exhibited drastically different 
-(1S,2R)-indandiol and 1-indenol. The cis-(1S,2R)-indandiol
formed by KY1 results from nonenzymatic hydrolysis of (1S,2R)-indan oxide produced from indene-induced monooxygenase activity. Under indene-induced conditions, the naphthalene dioxygenase in KY1 is largely inactive, as suggested by the lack of 1-indenol or 1-indanone produced. The pathway for indene bioconversion in KY1 based on this evidence was modified as shown in Fig. 1 .
Quantification of Network Fluxes. Because of its branched nature, the KY1 indene bioconversion network constitutes an underdetermined system requiring, as such, additional constraints for complete determination and confirmation of the pathway fluxes depicted in Fig. 1 for a representative steady state (0.065 h Ϫ1 dilution rate and 100 ppm indene air feed concentration; ref. 8) . Additional information was generated by 14 C-tracer experiments in the form of (i) measures of the flux split ratio to trans-and cis-(2R)-indandiol formation from indan oxide hydrolysis, (ii) redundant measurement of the indene uptake flux determined from the chemostat gas-phase measurements, and (iii) direct calculation of the trans-(1R,2R)-indandiol dehydrogenase flux (8) . These fluxes were determined by solving the metabolite balances for the system of reactions depicted in Fig. 1 using metabolite uptake and excretion rates determined from steadystate metabolite data (Table 1) with the additional constraints generated by the 14 C-tracer experiments described above. It is noted that under all conditions investigated, the flux through the monooxygenase enzyme accounted for at least 94% of the total indene converted.
Target Identification. The results of this flux analysis and the state of knowledge regarding Rhodococcus genetics point to the selective hydrolysis of indan oxide to trans-(1R,2R)-indandiol as the key target for improving (2R)-indandiol selectivity further. This type of transformation is catalyzed by epoxide hydrolases (13, 14) for many arene oxides including indan oxide (15) . This pathway change would favor the formation of the final desirable product, trans-(1R,2R)-indandiol, at the expense of the byproduct 1-keto-2-hydroxy-indan. Furthermore, the simplicity of this modification makes it vastly preferable relative to the multiple knockouts of dehydrogenases and͞or undesired oxygenases that could alternatively be pursued toward the same objective.
Flux Redistribution. To implement the change suggested from flux analysis, the limA gene encoding the Rhodococcus erythropolis DCL14 limonene-1,2-epoxide hydrolase (16 -18) was constructed by template-free PCR and placed in the expression plasmid pDS3 (Fig. 2) . After the addition of (1S,2R)-indan oxide to KY1(pDS3) cell lysate, a significant increase in the rate of formation of trans-indandiol was observed relative to that of KY1 and controls (Fig. 4) . SDS͞PAGE of the crude lysates showed a clear band at 17 kDa, which is the predicted size of this epoxide hydrolase (17) .
We subsequently tested the ability of the recombinant strain KY1(pDS3) to preferentially convert indene to trans-indandiol in batch bioconversions. KY1(pDS3) showed an improved overall indene conversion selectivity to trans-indandiol over that observed for KY1 batch cultures (Fig. 5 A and B) . As expected, the indene metabolite profiles observed in the control KY1(pAL282) bioconversion were consistent with those obtained with the KY1 parent strain. The improvement exhibited by KY1(pDS3) was pronounced during the initial period of the fermentation. For Ϸ25 h after the addition of indene, transindandiol was the primary terminal product formed with an average selectivity of Ϸ95%, which presumably resulted from the newly introduced epoxide hydrolase activity on the (1S,2R)-indan oxide formed by the indene monooxygenase. After this initial period, indan oxide began to accumulate, and cis-(1S,2R)-indandiol and 1-keto-2-hydroxy-indan accumulated after indan oxide reached a concentration of Ϸ150 mg͞liter. This unusual indene bioconversion profile is likely the result of an initial epoxide-hydrolase activity followed, at later times, with the competing nonenzymatic hydrolysis of indan oxide as the oxide concentration in the extracellular medium increases. The epoxide hydrolase may deactivate with time or be inhibited by the rising concentrations of some indene metabolites. Another possibility is that indan oxide formed by a membrane-bound monooxygenase is accompanied by significant indan oxide efflux to the medium and subsequent nonenzymatic hydrolysis yielding cis-indandiol.
Additional studies demonstrated that the flux split ratio of indan oxide hydrolysis is strongly pH-dependant, with transindandiol being the primary product formed at pH Ͼ 7.0. Of particular interest was the dramatic increase in the relative amount of trans-indandiol formed at pH 8.0 and higher. At pH 10.0, 97% of the indan oxide was hydrolyzed to trans-(1R,2R)-indandiol (80% ee). The total indan oxide hydrolysis rate is not affected substantially at pH values between 7.0 and 10.0. At lower pH, a substantial increase in both hydrolysis rate and the relative amount of cis-(1S,2R)-indandiol formed was observed.
Consequently, strain KY1(pDS3) was cultivated in a batch fermentor, and after indene-feed initiation and uptake in lateexponential phase, the culture pH was adjusted to 8.6. This culture showed dramatically improved indene bioconversion profiles over previous cultures of either KY1 or KY1(pDS3) at physiological pH (Fig. 5C ). No more than 25 mg͞liter of the by-product 1-keto-2-hydroxy-indan accumulated at any point in the medium compared with Ϸ300 mg͞liter for the KY1(pDS3) (pH 7.0) fermentation. Trans-indandiol was produced by KY1(pDS3) (pH 8.6) at greater than 92% selectivity throughout the culture and was resolved to 100% purity by the end of the bioconversion because of the slow degradation of 1-keto-2-hydroxy-indan.
Discussion
This work has applied the concepts and tools of metabolic engineering in creating an effective combination of a new recombinant Rhodococcus strain and fermentation environment capable of complete conversion of indene to trans-(1R,2R)-indandiol product. A mutant strain with a drastically improved chiral indandiol product profile was generated by applying proper selective pressure to chemostat cultures of Rhodococcus sp. The isolation of the KY1 strain represents a different and potentially valuable application of the chemostat system whereby cells are sustained on a carbon source but are used for the conversion of a different substrate that is fed to the system. The improvement observed with respect to indene bioconversion most likely is caused by a stereospecific monooxygenase of high activity catalyzing the conversion of indene to indan oxide of (2R) chirality and the elimination of a toluene-induced dioxygenase pathway. This modification resulted in doubling the product yield with no significant change in productivity at lower indene concentrations. Further productivity increases are obtained by increasing indene-feed concentration (Table 1) presumably caused by greater induction of the monooxygenase activity.
The approach presented here is applicable also to other bioconversion systems where maximal production of chiral intermediates is sought through bioconversion network optimization (19) . This study also demonstrates the importance of rigorously defining the bioconversion network and determining the magnitude of the network fluxes to identify targets for selectivity improvement rationally. Flux distributions were instrumental in identifying targets in the bioconversion network for further genetic work in the KY1 strain to eliminate the remaining side-products. Analysis of the metabolic fate of indan oxide in the KY1 bioconversion network revealed the nonenzymatic hydrolysis of this intermediate to both (2R)-indandiol diastereomers. This information permitted us to identify the indan oxide hydrolysis reaction as the prime candidate for modulation with the objective of improving (2R)-indandiol selectivity. Through two approaches the (2R)-indandiol yield and selectivity was increased to at least 90%, as suggested by the KY1 f lux distribution. This work has demonstrated that KY1(pDS3) is a potential production strain capable of producing trans-(1R,2R)-indandiol from indene at high selectivity. Further optimization of bioconversion conditions is likely to improve the product titer obtained in this study. In particular, the use of a two-phase system similar to that used previously should minimize exposure of the cells to the possibly toxic and͞or inhibitory indene metabolites (4, 7, 20) .
The methods and results of this work have broad implications for the design of metabolic engineering approaches to biocatalyst design in so-called ''uncharacterized'' biological systems with poorly characterized biochemistry and genetics, particularly with respect to the role of chemostats in strain-improvement programs.
